NPs coated with MBB2ΔCH2, targeting β2GPI, bound to endothelial cells within 30 minutes from injection and were effective in preventing in vivo binding of IgG purified from APS patients to endothelial cells and their prothrombotic activity. This evidence concerns the gene APOH and autoimmune polyendocrinopathy.